Cochlear profit up
Tuesday, 12 August, 2008
In a difficult year, Cochlear [ASX: COH] has posted excellent year-end results, with net profit up 15 per cent from last year.
Total revenue was $601.7 million, up eight per cent, for a net profit after tax of $115.2 million, slightly below forecasts.
Sales revenue has grown 18 per cent, after accounting for the appreciation of the Australian dollar.
Shareholders will be rewarded with a dividend of 80 cents per share.
The company said it expected double-digit growth again next year.
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
